Clinical Locations
-
Board Certification
American Board of Internal MedicineAmerican Board of Internal Medicine (Sub: Hematology)American Board of Internal Medicine (Sub: Medical Oncology)Patient Rating
4.9 /5( out of 107 reviews )The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.
The scale on which responses are measured is 1 to 5 with 5 being the best score.
Patient Comments
Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.
May 25, 2025SUGAR HOUSE HEALTH CENTERI am extremely fortunate to have her as my oncologist. She is obviously brilliant and exceptionally well educated. I trust her. She is also compassionate and kind.
May 23, 2025HUNTSMAN CANCER CENTERAhhhh my excellent Doctor, very humane and explained my treatment very well. [TRANSLATED]
May 04, 2025HUNTSMAN CANCER CENTERDr Chalmers is always kind and caring and provides excellent care. She listens to my questions and concerns. She and her team are always supportive and quick to respond to my questions and needs.
April 18, 2025HUNTSMAN CANCER CENTERPersonable, professional, cautiously optimistic.
February 27, 2025HUNTSMAN CANCER CENTERShe is interested in me and has a very pleasant happy way about her that makes being there a good experience.
February 25, 2025HUNTSMAN CANCER CENTERVery capable and a good listener
November 25, 2024SUGAR HOUSE HEALTH CENTERNever stops looking for ways to improve your care
October 29, 2024HUNTSMAN CANCER CENTERDr Chalmers is a calming person. I feel as if I have all the time in the world with her.
September 28, 2024HUNTSMAN CANCER CENTERVery positive and caring. I could tell she was very knowledgeable. Made me feel comfortable Told me of the treatment to follow
-
Board Certification and Academic Information
Academic Departments Internal Medicine -Assistant Professor (Clinical)
Academic Divisions Oncology
Board Certification American Board of Internal MedicineAmerican Board of Internal Medicine (Sub: Hematology)American Board of Internal Medicine (Sub: Medical Oncology)Education history
Fellowship Hematology and Medical Oncology - Rush ÑÇÖÞ×ÔοÊÓƵ Medical Center Fellow Residency Internal Medicine - Rush ÑÇÖÞ×ÔοÊÓƵ Medical Center Resident Professional Medical Medicine - Drexel ÑÇÖÞ×ÔοÊÓƵ College of Medicine M.D. Undergraduate Dartmouth College B.A. Selected Publications
Journal Article
- Puri S, Malani R, Chalmers A, Kerrigan K, Patel SB, Monynahan K, Cannon L, Blouw B, Akerley W (2023). Keeping a track on leptomeningeal disease in non-small cell lung cancer: A single-institution experience with CNSide(TM). Neurooncol Adv, 6(1), vdad150. ()
- Kerrigan K, Patel SB, Haaland B, Ose D, Weinberg Chalmers A, Haydell T, Meropol NJ, Akerley W (2020). Prognostic Significance of Patient-Reported Outcomes in Cancer. JCO Oncol Pract, 16(4), e313-e323. ()
- Chalmers AW, Patel S, Boucher K, Cannon L, Esplin M, Luckart J, Graves N, Van Duren T, Akerley W (2019). Phase I Trial of Targeted EGFR or ALK Therapy with Ipilimumab in Metastatic NSCLC with Long-Term Follow-Up. Target Oncol, 14(4), 417-421. ()
- Chalmers A, Cannon L, Akerley W (2018). Adverse Event Management in Patients with BRAF V600E-Mutant Non-Small Cell Lung Cancer Treated with Dabrafenib plus Trametinib. Oncologist, 24(7), 963-972. ()
Editorial
- Chalmers AW, Patel SB, Akerley W (2018). Immunotherapy after chemoradiotherapy in stage III non-small cell lung cancer: a new standard of care? J Thorac Dis, 10(3), 1198-1200. ()
Letter
- Chalmers A, Akerley W (2017). Retrospective, Multi-Institutional Analysis of Sequential Treatment of Brain Metastases in Treatment-Naïve, Epidermal Growth Factor Receptor-Mutated Non-Small-Cell Lung Cancer Should Not Define the Standard of Practice. [Letter to the editor]. J Clin Oncol, 35(20), 2340. ()
-
News & Podcasts
Huntsman Cancer Institute News